BRAF mutant

Quiénes somos

  • enero 17, 2024
    ZN-c3 in Adult Participants With BRAF mutant Metastatic Colorectal Cancer
  • 9 de enero de 2024
    A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer ( SEAMARK )
  • 5 de abril de 2022
    Dabrafenib + Trametinib + PDR001 en cáncer colorrectal